Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations
Open Access
- 1 March 1991
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (3) , 560-566
- https://doi.org/10.1128/aac.35.3.560
Abstract
We compared the inoculum effects of 105 recent clinical isolates of the family Enterobacteriaceae on cefoxitin, other cephalosporins, aztreonam, and three beta-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) and their penicillin-derived components. Piperacillin and aztreonam showed the largest inoculum effect, and cefoxitin showed the smallest. The other cephalosporins tested (cefotetan, ceftizoxime, and ceftriaxone) showed an intermediate inoculum effect. In general, the inoculum effect was of greater magnitude for the penicillin and beta-lactamase inhibitor combinations than for the cephalosporins tested. Bactericidal activity was assayed and morphologic changes were monitored for selected strains exhibiting a large inoculum effect. MICs correlated with bactericidal activity at an inoculum level of 10(5) CFU/ml, while activity at 10(8) CFU/ml was variable. Cefoxitin demonstrated the least filamentous transformation and the most rapid bactericidal activity. Aztreonam showed the most marked filamentous transformation and was no longer bactericidal at 10(8) CFU/ml. The beta-lactamase inhibitor combinations showed variable bactericidal activity, and regrowth occurred with a number of strains with all three agents tested.Keywords
This publication has 18 references indexed in Scilit:
- Relevance of the inoculum effect of antibiotics in the outcome of experimental infections caused by Escherichia coliJournal of Antimicrobial Chemotherapy, 1990
- AMOXYCILLIN/CLAVULANATE RESISTANT ESCHERICHIA COLIThe Lancet, 1988
- Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria: Rationale for selective decontamination of the digestive tractThe American Journal of Medicine, 1987
- Variation in the potentiation of β-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteriaJournal of Antimicrobial Chemotherapy, 1986
- Inoculum effect of beta-lactam antibiotics on EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 1985
- Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Staphylococcal -Lactamase and Efficacy of -Lactam Antibiotics: In Vitro and in Vivo EvaluationThe Journal of Infectious Diseases, 1983
- Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1980
- The β-lactamase stability of a novel β-lactam antibiotic containing a 7 α-methoxyoxacephem nucleusJournal of Antimicrobial Chemotherapy, 1980